TD AMERITRADE INVESTMENT MANAGEMENT, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
TD AMERITRADE INVESTMENT MANAGEMENT, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$0
-100.0%
0
-100.0%
0.00%
Q2 2023$20.0%1340.0%0.00%
Q1 2023$2
-71.4%
134
-67.9%
0.00%
Q4 2022$7
-99.9%
417
-47.2%
0.00%
Q3 2022$10,000
-28.6%
790
-19.4%
0.00%
Q2 2022$14,000
-39.1%
980
-39.0%
0.00%
Q1 2022$23,000
-17.9%
1,606
-21.1%
0.00%
Q4 2021$28,000
-42.9%
2,035
-25.4%
0.00%
Q3 2021$49,000
+19.5%
2,729
+12.4%
0.00%
Q2 2021$41,000
-30.5%
2,427
-24.5%
0.00%
Q1 2021$59,0000.0%3,2150.0%0.00%
Q4 2020$59,000
+20.4%
3,215
+17.8%
0.00%
Q3 2020$49,000
-3.9%
2,729
-4.1%
0.00%
Q2 2020$51,000
-7.3%
2,846
-21.6%
0.00%
-100.0%
Q1 2020$55,000
-32.9%
3,630
-12.4%
0.00%0.0%
Q4 2019$82,000
+24.2%
4,144
+7.2%
0.00%0.0%
Q3 2019$66,0000.0%3,865
+3.9%
0.00%0.0%
Q2 2019$66,000
+17.9%
3,720
+35.9%
0.00%
Q1 2019$56,000
+24.4%
2,737
+1.6%
0.00%
Q4 2018$45,0002,6940.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders